Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hunterase in Hunter Syndrome Patients < 6 Years
NCT01645189Phase 3Completed
- Sponsor
- GC Biopharma
- Start
- Jul 2012
- Primary completion
- Sep 2013
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Idursulfase beta in mucopolysaccharidosis type II, sponsored by GC Biopharma. Started Jul 2012; status: completed.
02
Drugs
Idursulfase beta
03
Conditions
mucopolysaccharidosis type II
Beyond the preview
Go deeper on NCT01645189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01645189.